Table 3.
ACR-free group (n =20) | ACR group (n =16) | P-value | |
---|---|---|---|
LV-parameters | |||
LV-GLS 12 months (%) | −16.8 ± 2.2 | −14.4 ± 2.4 | <0.01* |
ΔLV-GLS 0–12 months | −4.6 ± 1.2 | −2.8 ± 2.7 | 0.19 |
ΔLV-GLS 1–12 months | −2.9 ± 3.5 | 0.1 ± 2.4 | <0.01* |
LV-ENDO-GLS 12 months (%) | −20.1 ± 2.7 | −17.5 ± 2.8 | <0.05* |
ΔLV-ENDO-GLS 0–12 months | −4.1 ± 5.0 | −3.0 ± 2.9 | 0.44 |
ΔLV-ENDO-GLS 1–12 months | −2.6 ± 3.9 | 0.4 ± 2.5 | <0.05* |
LV-TTP 12 months (ms) | 39.1 ± 10.8 | 48.3 ± 16.5 | 0.06 |
ΔLV-TTP 0–12 months | −19.8 ± 22.5 | −19.9 ± 26.1 | 0.99 |
ΔLV-TTP 1–12 months | −11.7 ± 16.0 | −1.8 ± 15.0 | 0.08 |
LV-GCS 12 months (%) | −21.3 ± 5.3 | −19.6 ± 3.2 | 0.26 |
ΔLV-GCS 0–12 months | −2.1 ± 5.0 | 0.2 ± 5.2 | 0.23 |
ΔLV-GCS 1–12 months | −1.2 ± 5.8 | 0.3 ± 4.4 | 0.44 |
LVEF 12 months (%) | 64.4 ± 5.9 | 65.1 ± 7.2 | 0.75 |
ΔLVEF 0–12 months | 3.4 ± 10.8 | 4.3 ± 7.5 | 0.79 |
ΔLVEF 1–12 months | 0.2 ± 5.9 | −0.8 ± 5.8 | 0.64 |
RV-parameters | |||
TAPSE 12 months (mm) | 15.3 ± 2.8 | 13.2 ± 2.1 | <0.05* |
ΔTAPSE 0–12 months | 3.2 ± 3.8 | 1.4 ± 1.3 | 0.08 |
ΔTAPSE 1–12 months | 1.2 ± 4.3 | 0.5 ± 2.5 | 0.57 |
Data are presented as mean ± standard deviation.
LV, left ventricle; GLS, global longitudinal strain; ENDO, endocardium; TTP, time to peak; GCS, global circumferential strain; LVEF, left ventricular ejection fraction; RV, right ventricle; TAPSE, tricuspid annular plane systolic excursion.
*P < 0.05.